1. $OSIR Osiris to Present Advanced Research on Chronic Wound Treatment Using Cryopreserved Placental Membranes http://www.finances.com/company-news/90473-osiris-to-present-advanced-research-on-chronic-wound-treatment-using-cryopreserved-placental-membranes.htm

  2. Osiris Therapeutics just filed its Additional definitive proxy soliciting materials and Rule 14(a)(12) material http://www.conferencecalltranscripts.org/include/?location=http://www.sec.gov/Archives/edgar/data/1360886/000110465915031984/0001104659-15-031984-index.htm $OSIR

  3. $OSIR: New SEC Filing for OSIR: Form DEF 14A, No. 0001047469-15-004167 http://stocknewsflow.com/1360886_000104746915004167_0001047469-15-004167

  4. Osiris Therapeutics releases salary data. CEO sees compensation rise 236% http://www.conferencecalltranscripts.org/proxy/summary/?id=1649965 $OSIR

  5. Osiris Therapeutics $OSIR has the best stem cells therapy to treat diabetes wound https://www.retailinvestor360.com/biotech/463-osiris-stem-cells-to-compliment-mannkind-s-afrezza-in-disrupting-diabetes-market.html

  6. $OSIR does someone know something untoward here

  7. $OSIR Since last ER, stock dropped 8%. Will drop continue aftr ER on 5/8 Before Open? http://stocksearning.com/q.aspx?Sys=OSIR

  8. The Medicines Co. s New Minocin Formulation FDA Approved. But There Are Better Bets... $MDCO $AVEO $OSIR $HZNP http://www.talkmarkets.com/content/stocks--equities/the-medicines-cos-new-minocin-formulation-approved?post=63336

  9. The Medicines Co. s New Minocin Formulation FDA Approved But There Are Better Bets $MDCO $AVEO $OSIR $HZNP http://www.talkmarkets.com/content/stocks--equities/the-medicines-cos-new-minocin-formulation-approved?post=63336

  10. The Medicines Co. s New Minocin Formulation FDA Approved But There Are Better Bets $MDCO $AVEO $OSIR $HZNP http://www.talkmarkets.com/content/stocks--equities/the-medicines-cos-new-minocin-formulation-approved?post=63336

  11. Other preliminary proxy statements http://www.conferencecalltranscripts.org/no/summary2/?id=1624330 $OSIR

  12. Osiris: Departures Of Directors Or Principal Officers, Election Of Directors, Appointment Of Principal Officers http://www.conferencecalltranscripts.org/8/summary2/?id=1624315 $OSIR

  13. $OSIR: New SEC Filing for OSIR: Form 8-K, No. 0001104659-15-028902 http://stocknewsflow.com/1360886_000110465915028902_0001104659-15-028902

  14. Earnings announcement: $OSIR is scheduled to report quarterly earnings on Fri, May 8 2015

  15. $OSIR $SYK: Osiris Therapeutics Announces First Quarter 2015 Financial Results Conference Call... http://stockwires.com/osiris-therapeutics-announces-first-quarter-2015-financial-results-conference-call

  16. $OSIR Osiris Therapeutics Announces First Quarter 2015 Financial Results Conference Call http://www.finances.com/company-news/85625-osiris-therapeutics-announces-first-quarter-2015-financial-results-conference-call.htm

  17. Osiris Therapeutic is also a leader in diabetes wound care https://www.retailinvestor360.com/biotech/463-osiris-stem-cells-to-compliment-mannkind-s-afrezza-in-disrupting-diabetes-market.html $OSIR

  18. 5 top stocks on NASDAQ (Apr. 13): $SNC, $BANX, $MARA, $OSIR, $UPLD http://www.nna100.com/stock_ranking.php?p=NASDAQ-Top-100-BUY-Rating-Stocks&d=2015-04-13

  19. I listened to his conference calls and I ll say that his public speaking is questionable, but his brain is highly powerful. $OSIR

  20. $OSIR former CEO Randall C. Mill was the first one to successfully innovate stem cells for treating diabetes wounds https://www.retailinvestor360.com/biotech/463-osiris-stem-cells-to-compliment-mannkind-s-afrezza-in-disrupting-diabetes-market.html

  21. $OSIR weekly/monthly patterns continue to look explosive

  22. $OSIR Looks like there was an opportunity to make money here. The buy rating is set to 6.5, target: 21.52. http://www.9trading.com/index.php?symbol=osir

  23. $OSIR nice move up today!

  24. $OSIR Management Update: Announced the promotion of Alla Danilkovitch, Ph.D., to serve as Chief Scientific Officer.

  25. Osiris Therapeutics Announces Alla Danilkovitch, Ph.D., As Chief Scientific Officer http://www.conferencecalltranscripts.org/8/summary/?id=1602994 $OSIR